|
SFRS11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.89129999999383E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.356260E-03 |
| Normal-vs-Stage2 |
2.13289999999589E-05 |
| Normal-vs-Stage3 |
1.54850000000373E-06 |
| Normal-vs-Stage4 |
8.419000E-03 |
| Stage1-vs-Stage2 |
2.232000E-02 |
| Stage1-vs-Stage3 |
1.860150E-02 |
| Stage1-vs-Stage4 |
5.813800E-01 |
| Stage2-vs-Stage3 |
5.731600E-01 |
| Stage2-vs-Stage4 |
2.198600E-01 |
| Stage3-vs-Stage4 |
3.488200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.378300E-04 |
| Normal-vs-AfricanAmerican |
3.702100E-02 |
| Normal-vs-Asian |
3.410000E-02 |
| Caucasian-vs-AfricanAmerican |
7.426600E-01 |
| Caucasian-vs-Asian |
3.377800E-01 |
| AfricanAmerican-vs-Asian |
7.226400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.036100E-03 |
| Normal-vs-Female |
2.12880000000082E-05 |
| Male-vs-Female |
3.887800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.215900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.772870E-04 |
| Normal-vs-Age(61-80Yrs) |
2.31229999999583E-05 |
| Normal-vs-Age(81-100Yrs) |
1.68871999999265E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.163560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.076410E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.741800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.348000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.518100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.104600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.956300E-04 |
| Classical-VS-Follicular |
2.089600E-02 |
| Classical-VS-Other |
2.420400E-01 |
| Classical-VS-Normal |
1.522080E-03 |
| Tall-VS-Follicular |
2.892600E-01 |
| Tall-VS-Other |
1.336630E-01 |
| Tall-VS-Normal |
3.84549999954409E-07 |
| Follicular-VS-Other |
1.014040E-01 |
| Follicular-VS-Normal |
9.85059999999427E-05 |
| Other-VS-Normal |
8.987400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52406999999188E-05 |
| Normal-vs-N1 |
4.043600E-01 |
| N0-vs-N1 |
1.612040E-02 |
|
|
